-
Quartzy Opens Second Distribution Warehouse, Expanding Options To Serve Software Customers
Bio-IT World | Quartzy, a free online laboratory supply management and ordering platform, has expanded distribution operations with a new 40,000 square foot warehouse in Hayward, California, and grown its lab supply portfolio to over three million SKUs.
Jul 19, 2018
-
Tetraphase Selects SHYFT To Support Data And Analytics For Commercial Launch Readiness
Bio-IT World Brief | SHYFT Analytics announced Tetraphase has selected its platform to support the anticipated commercial launch of eravacycline, its lead antibiotic candidate developed to address multidrug-resistant bacteria.
Jul 18, 2018
-
AWS Unveils New HPC Instances With Fast Cores
TOP500 | Amazon Web Services has announced a new set of instances designed for applications that can benefit from high core performance.
Jul 18, 2018
-
Government Insurers Balk At Paying For CAR-T Cancer Drug
NPR | Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.
Jul 17, 2018
-
Another CRISPR Calamity? U.K. Team Reports CRISPR-Induced Gene Rearrangements
GEN | Scientists at the Wellcome Sanger Institute in the U.K. have reported another potential hurdle for the CRISPR community, publishing findings today that call the precision of CRISPR-Cas9 gene editing into question.
Jul 16, 2018
-
Leaders In Biobanking Congress: Unlocking The Potential
Bio-IT World | This year, the 10th annual Leaders in Biobanking Congress will take place in Cleveland, Ohio from October 14-16. Biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners will converge to discuss the various aims for biospecimen collections, from basic research to clinical trials.
Jul 16, 2018
-
Superbugs Win Another Round As Big Pharma Leaves Antibiotics
Bloomberg | The fight against life-threatening infections suffered another blow when one of the world's biggest drugmakers waved the white flag. Novartis is the latest drug giant to end antibacterial and antiviral research, joining the like of AstraZeneca, Sanofi, and Allergan.
Jul 13, 2018
-
I'm Adopted, Should I Have DNA Testing?
Forbes | Should adoptees, or parents of adoptees, consider direct-to-consumer genetic testing kits to gain more information on health risks, ancestry, or to find biological relatives? A certified genetic counselor reviews the pros and cons you should know before you spit.
Jul 11, 2018
-
BioIVT Acquires Optivia, Adding Transporter Assay Products And Services To Its ADME-Tox Portfolio
Bio-IT World Brief | BioIVT today announced that it has acquired Santa Clara, CA-based Optivia and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.
Jul 9, 2018
-
JUWELS Becomes Germany’s Most Powerful Supercomputer
TOP500 | The first module of JUWELS, a supercomputer that is expected to be a model for future exascale systems, is now up and running at the Jülich Supercomputing Centre in Germany.
Jul 5, 2018
-
Why Data Science Is An Art – And How To Support The People Who Do It
Elsevier Connect | In his recent talk at the Bio-IT World Conference, Elsevier’s Jabe Wilson used examples of data science undertaken at Elsevier to illustrate why data science is an art – and how best to support data scientists based on this insight.
Jul 3, 2018
-
Match Cutting-Edge Research With Next Generation Data Solutions
Bio-IT World Contributed Commentary | With data emerging as the undisputed driver for 21st Century medicine, it is becoming clear that we cannot expect to design our next generation data infrastructure on the technologies of the last century—technologies that were never intended to handle today’s extreme data volume and workloads.
Jul 2, 2018
-
From Discovery To Trials In 18 Months: MD Anderson’s Therapeutics Discovery Team Approach
Bio-IT World | At MD Anderson, the Therapeutics Discovery team aims to develop new treatment options for MD Anderson patients in a much faster way. Two studies published in Nature Medicine earlier this month support the approach, they say.
Jun 29, 2018
-
Helix Announces Expansion Of Its Executive Team, New Denver Office
Bio-IT World Brief | Helix today announced a new CFO, CMO, and CPO, coupled with the acquisition of Denver-based HumanCode.
Jun 28, 2018
-
Deloitte, PerkinElmer, iRODS, And More: News From June 2018
Bio-IT World | June featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Deloitte, PerkinElmer, iRODS, and more.
Jun 27, 2018
-
DDN Announces A3I Solutions: Parallel Data Platforms For AI
Bio-IT World Brief | DataDirect Networks today announced a set of data platforms for artificial intelligence and deep learning. Engineered for the AI data center, DDN’s A3I solutions are optimized to handle the spectrum of AI activities concurrently from data ingest and preparation to training, validation and inference.
Jun 26, 2018
-
Deep Learning Tool Empowers Biologists, Speeds Screening
Bio-IT World | Traditional high content screening is labor- and time-intensive, and many groups are working to apply deep learning to image analysis. Genedata worked with AstraZeneca to validate a deep learning workflow tool for biologists that can be “unsupervised”—it works without re-engineering across different assay types and settings.
Jun 25, 2018
-
Challenges In Bringing Personalized Cancer Vaccines To The Clinic
Bio-IT World Contributed Commentary | The cancer vaccine industry faces a challenge: How to transition from prediction to effective vaccine therapy?
Jun 21, 2018
-
Alexion’s Quest To Test The Algorithm Of Rare Disease Diagnosis
Bio-IT World | Alexion, in collaboration with EPAM, has developed a software competition platform to allow the objective comparison of contributed algorithms for automated rare disease diagnosis.
Jun 20, 2018
-
Roche Pays $2.4 Billion For Rest Of Cancer Expert Foundation Medicine
Reuters | Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.
Jun 19, 2018